Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Mycobacteriology and Aerobic Actinomycetes

Rapid Detection of Smear-NegativeMycobacterium tuberculosis by PCR and Sequencing for Rifampin Resistance with DNA Extracted Directly from Slides

Madhumita Patnaik, Karsten Liegmann, James B. Peter
Madhumita Patnaik
Research Department, Specialty Laboratories, Inc., Santa Monica, California 90404
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karsten Liegmann
Research Department, Specialty Laboratories, Inc., Santa Monica, California 90404
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James B. Peter
Research Department, Specialty Laboratories, Inc., Santa Monica, California 90404
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JCM.39.1.51-52.2001
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Conventional methods for identification of Mycobacterium tuberculosis from culture can take 6 weeks. To facilitate the rapid detection of M. tuberculosis and to assess the risks of drug resistance, we developed a technique of eluting DNA directly from sputum slides and performing PCR for the detection of M. tuberculosis DNA, followed by sequencing the rpoBgene to detect rifampin resistance. This entire process requires only 48 h. Forty-seven sputum specimens submitted for microscopy for detection of acid-fast bacilli (AFB) and for mycobacterial culture and susceptibility testing were assessed after elution from the slides and extraction. M. tuberculosis-specific DNA was amplified in a nested PCR with previously described primers (primers rpo95-rpo293 and rpo105-rpo273), followed by analysis on a 4% agarose gel for a 168-bp product. Automated sequencing was performed, and the sequences were aligned against a database for detection of anomalies in therpoB gene (codons 511 to 533) which indicate rifampin resistance. Of the 47 sputum specimens tested, 51% (24 of 47) were culture positive (time to positive culture, 2 to 6 weeks). Smears for AFB were positive for 58% (14 of 24) of the specimens and were negative for 42% (10 of 24) of the specimens. All 24 culture-positive sputum specimens (14 microscopy-positive and 10 microscopy-negative sputum specimens) were positive by PCR with eluates from the smears. Forty-nine percent (23 of 47) of the sputum specimens were negative forM. tuberculosis by smear, culture, and PCR. Of the isolates from the culture-positive samples, five were rifampin resistant by sequencing; all five were also rifampin resistant by in vitro susceptibility testing. Of these rifampin-resistant M. tuberculosis isolates, two were microscopy negative for AFB. Patients who are negative for AFB and culture positive for M. tuberculosis can now be identified within a day, allowing institution of therapy and reducing isolation time and medical costs.

In the last decade, tuberculosis has reemerged as one of the leading causes of death, killing nearly 3 million people annually. With an estimated 8.8 million new cases every year and the continued proliferation of drug resistance, the public health implications are immense (5, 14). Conventional methods for positive identification of Mycobacterium tuberculosis from culture can take up to 6 weeks, and it has been reported that tuberculosis can be transmitted from 17% of patients who are smear negative, culture positive for M. tuberculosis(1). To facilitate the rapid detection of M. tuberculosis we have developed a technique of eluting DNA directly from a sputum slide and performing a nested PCR amplification. Additionally, this PCR product (a section of the rpoB gene) may be sequenced to determine missense mutations, insertions, or deletions which correlate at >96% with rifampin resistance (13). This entire process requires only 48 h.

MATERIALS AND METHODS

Forty-seven sputum specimens were obtained from the Microbiology Department at Specialty Laboratories for which smear results for acid-fast bacilli (AFB) and culture results had been determined. The sputa were spread onto slides, dried on a 75°C hot plate, and stored at room temperature for a period of at least a month to assess the acceptability of room temperature transport and storage and the stability of DNA on slides. The slides were placed into 50-ml centrifuge tubes, and a proprietary solution was used to elute the DNA. The DNA was then processed by proteinase K digestion, followed by extraction with phenol-chloroform. The primers used were as follows: rpo95 (5′-CCA CCC AGG ACG TGG AGG CGA TCA CAC-3′) and rpo293 (5′-AGT GCG ACG GGT GCA CGT CGC GGA CCT-3′) for the primary PCR and rpo105 (5′-CGT GGA GGC GAT CAC ACC GCA GAC GT-3′) and rpo273 (5′-GAC CTC CAG CCC GGC ACG CTC ACG T-3′) for the secondary PCR. A nested PCR was performed with the following conditions: 94°C for 1 min, 72°C for 1 min (primary PCR) and 74°C for 1 min (secondary PCR), and 72°C for 1 min for a total of 35 cycles.

Amplified products were separated by agarose gel electrophoresis on a 4% agarose gel, visualized with ethidium bromide, and photographed. The remainder of the PCR product for those samples positive forM. tuberculosis were then purified and sequenced. Sequencing reactions were performed with the Dye Terminator Cycle Sequencing Ready Reaction kit (Perkin-Elmer), and automated sequencing used a 4% acrylamide gel on the ABI 377 DNA Sequencer (Applied Biosystems). The generated sequences were aligned against the sequences in a database for detection of mutations, insertions, and deletions in therpoB gene (codons 511 to 533) to indicate rifampin resistance (9, 15).

RESULTS

Of the 47 sputum specimens tested, 51% (24 of 47) were culture positive (time to positive culture, 2 to 6 weeks; median time, 14 days). Forty-nine percent (23 of 47) of the sputum specimens were negative for M. tuberculosis by smears for AFB and culture.

All 24 culture-positive sputum specimens (14 positive for AFB and 10 negative for AFB) were positive by PCR for M. tuberculosisDNA on eluates from the smears, and correspondingly, all 23 culture-negative sputum specimens (negative for AFB) were negative by PCR with eluates from the smear. Nested PCR shows a clinical sensitivity of 100%, whereas detection of AFB by microscopy has a sensitivity of only 58%.

Rifampin resistance in culture-positive sputa.Of the isolates in the culture-positive samples, five were rifampin resistant as determined by rpoB gene sequencing; all five were also rifampin resistant as determined by in vitro susceptibility testing. Of these five isolates, two were negative for AFB by microscopy. (Table1).

View this table:
  • View inline
  • View popup
Table 1.

Results for rifampin resistance testing for 24 culture-positive samples

DISCUSSION

Slide microscopy for the detection of AFB is a convenient, rapid, and economical test used for determination of M. tuberculosis infection. However, recent studies have shown that up to half of the new cases of tuberculosis are smear negative (2). This leads to delays in the institution of therapy, reduced rates of patient isolation, and increased medical costs.

The elution of nucleic acids directly from slides identical to those used for microscopy for AFB permits transport and storage of the samples to be assayed at room temperature (as opposed to the transport and storage of sputum at freezing temperatures). Thus, it allows many of the same aspects of convenience and economy found in microscopy for AFB. However, conventional nucleic acid amplification assays for direct detection of M. tuberculosis in smear-negative, culture-positive samples show low sensitivity (less than 60%) and less than optimal specificity (2, 3, 4, 10, 11, 12, 16, 17). The application of improved amplification techniques (in this case, nested PCR) allows greatly enhanced detection of smear-negative sputum specimens (8). Furthermore, rifampin resistance is detected using the amplification product as a template for sequencing for mutations conferring resistance, which is of practical interest as rifampin resistance represents a surrogate marker for multiple-drug resistant (MDR) M. tuberculosis (6, 14). The rapid detection of tuberculosis and rifampin resistance can substantially reduce the cost of inappropriate isolation of patients with risk factors for MDR M. tuberculosis (6).

Dye et al. (7) have published an extensive study on the global burden of tuberculosis and have shown that 80% of all incident tuberculosis cases are found in 22 countries, with more than half in five Southeast Asian countries. The case detection rates may also be low due to the extra burden of smear-negative disease, even in sophisticated testing facilities. These errors in case detection may be reduced by using the method described above on slides for detection of AFB for the earlier detection of smear-negative cases. The method may also be used as an aid for determination of appropriate treatment strategies for MDR M. tuberculosis prior to confirmation by culture.

These results demonstrate the feasibility of using nested PCR and sequencing of nucleic acids eluted directly from slides to detect the presence of M. tuberculosis and to determine resistance to rifampin in a manner far more rapid than culture determination and with greater sensitivity than microscopy for AFB.

ACKNOWLEDGMENT

We thank Taurica A. Rodgers for help in preparation of the manuscript.

FOOTNOTES

    • Received 17 May 2000.
    • Returned for modification 5 August 2000.
    • Accepted 22 October 2000.
  • Copyright © 2001 American Society for Microbiology

REFERENCES

  1. 1.↵
    1. Behr M. A.,
    2. Warren S. A.,
    3. Salamon H.,
    4. Hopewell P. C.,
    5. Ponce de Leon A.,
    6. Daley C. L.,
    7. Small P. M.
    Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli.Lancet3531999444449
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    1. Bennedsen J.,
    2. Thomsen V. O.,
    3. Pfyffer G. E.,
    4. Funke G.,
    5. Feldmann K.,
    6. Beneke A.,
    7. Jenkins P. A.,
    8. Hegginbothom M.,
    9. Fahr A.,
    10. Hengstler M.,
    11. Cleator G.,
    12. Klapper P.,
    13. Wilkins E. G.
    Utility of PCR in diagnosing pulmonary tuberculosis.J. Clin. Microbiol.34199614071411
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Clarridge J. E. III,
    2. Shawar R. M.,
    3. Shinnick T. M.,
    4. Plikaytis B. B.
    Large-scale use of polymerase chain reaction for detection of Mycobacterium tuberculosis in a routine mycobacteriology laboratory.J. Clin. Microbiol.31199320492056
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Doern G. V.
    Diagnostic mycobacteriology: where are we today? J. Clin. Microbiol. 34 1996 1873 1876
    OpenUrlFREE Full Text
  5. 5.↵
    1. Drobniewski F.,
    2. Pablos-Mendes A.,
    3. Raviglione M. C.
    Epidemiology of tuberculosis in the world.Semin. Respir. Crit. Care Med.181997419429
    OpenUrlCrossRef
  6. 6.↵
    1. Drobniewski F. A.,
    2. Watterson S. A.,
    3. Wilson S. M.,
    4. Harris G. S.
    A clinical, microbiological and economic analysis of a national service for the rapid molecular diagnosis of tuberculosis and rifampicin resistance in Mycobacterium tuberculosis.J. Med. Microbiol.492000271278
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.↵
    1. Dye C.,
    2. Scheele S.,
    3. Dolin P.,
    4. Pathania V.,
    5. Raviglione M. C.
    Global burden of tuberculosis: estimated incidence, prevalence and mortality by country.JAMA2821999677686
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    1. Garcia-Quintanilla A.,
    2. Garcia L.,
    3. Griselda T.,
    4. Navarro M.,
    5. Gonzalez J.,
    6. Jimenez de Anta M. T.
    Single-tube balanced heminested PCR for detecting Mycobacterium tuberculosis in smear-negative samples.J. Clin. Microbiol.38200011661169
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Kapur V.,
    2. Li L.,
    3. Iodeanescu S.,
    4. Hamrick M. R.,
    5. Wanger A.,
    6. Kreiswirth B. N.,
    7. Musser J. M.
    Characterization by automated DNA sequencing of mutations in the gene rpoB encoding the RNA polymerase β subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas.J. Clin. Microbiol.32199410951098
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Leburn L.,
    2. Matheiu D.,
    3. Saulnier C.,
    4. Nordmann P.
    Limits of commercial molecular tests for diagnosis of pulmonary tuberculosis.Eur. Respir. J.10199718741876
    OpenUrlAbstract
  11. 11.↵
    1. Nolte F. S.,
    2. Metchock B.,
    3. McGowan J. E. Jr.,
    4. Edwards A.,
    5. Kwumabua O.,
    6. Thurmond C.,
    7. Mitchell P. S.,
    8. Plikaytis B.,
    9. Shinnick T.
    Direct detection of Mycobacterium tuberculosis in sputum by polymerase chain reaction and DNA hybridization.J. Clin. Microbiol.31199317771782
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Shawar R. M.,
    2. El Zaatari F. A. K.,
    3. Nataraj A.,
    4. Clarridge J. E.
    Detection of Mycobacterium tuberculosis in clinical samples by two-step polymerase chain reaction and nonisotopic hybridization methods.J. Clin. Microbiol.3119936165
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Telenti A.,
    2. Imboden P.,
    3. Marchesi F.,
    4. Lowrie D.,
    5. Cole S.,
    6. Colston M. J.,
    7. Matter L.,
    8. Schopfer K.,
    9. Bodmer T.
    Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis.Lancet3411993647650
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    1. Telenti A.,
    2. Iseman M.
    Drug-resistant tuberculosis: what do we do now? Drugs 59 2000 171 179
    OpenUrlCrossRefPubMedWeb of Science
  15. 15.↵
    1. Whelen A. C.,
    2. Felmlee T. A.,
    3. Hunt J. M.,
    4. Williams D. L.,
    5. Roberts G. D.,
    6. Stockman L.,
    7. Persing D. H.
    Direct genotypic detection of Mycobacterium tuberculosis rifampin resistance in clinical specimens by using a single tube heminested PCR.J. Clin. Microbiol.331995556561
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Woods G. L.
    Molecular methods in the detection and identification of mycobacterial infections.Arch. Pathol. Lab. Med.123199910021006
    OpenUrlPubMedWeb of Science
  17. 17.↵
    1. Yuen K.,
    2. Yam W. C.,
    3. Wong L. P.,
    4. Seto W. H.
    Comparison of two automated DNA amplification systems with a manual one-tube nested PCR assay for diagnosis of pulmonary tuberculosis.J. Clin. Microbiol.35199713851389
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top
Download PDF
Citation Tools
Rapid Detection of Smear-NegativeMycobacterium tuberculosis by PCR and Sequencing for Rifampin Resistance with DNA Extracted Directly from Slides
Madhumita Patnaik, Karsten Liegmann, James B. Peter
Journal of Clinical Microbiology Jan 2001, 39 (1) 51-52; DOI: 10.1128/JCM.39.1.51-52.2001

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Clinical Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Rapid Detection of Smear-NegativeMycobacterium tuberculosis by PCR and Sequencing for Rifampin Resistance with DNA Extracted Directly from Slides
(Your Name) has forwarded a page to you from Journal of Clinical Microbiology
(Your Name) thought you would be interested in this article in Journal of Clinical Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Rapid Detection of Smear-NegativeMycobacterium tuberculosis by PCR and Sequencing for Rifampin Resistance with DNA Extracted Directly from Slides
Madhumita Patnaik, Karsten Liegmann, James B. Peter
Journal of Clinical Microbiology Jan 2001, 39 (1) 51-52; DOI: 10.1128/JCM.39.1.51-52.2001
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENT
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

DNA, Bacterial
Mycobacterium tuberculosis
polymerase chain reaction
sputum
Tuberculosis, Pulmonary

Related Articles

Cited By...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

 

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X